burosumab
Jump to navigation
Jump to search
Indications
Dosage
- 1 mg/kg every 2 weeks or 1.5 mg/kg every 4 weeks
Mechanism of action
- monoclonal antibody that inhibits FGF-23
More general terms
References
- ↑ Carpenter TO, Whyte MP, Imel EA Burosumab Therapy in Children with X-Linked Hypophosphatemia. N Engl J Med 2018; 378:1987-1998. May 24, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29791829 https://www.nejm.org/doi/full/10.1056/NEJMoa1714641